Impaired sense of smell in a Drosophila Parkinson's model.

Parkinson’s disease (PD) is one of the most common neurodegenerative disease characterized by the clinical triad: tremor, akinesia and rigidity. Several studies have suggested that PD patients show disturbances in olfaction at the earliest onset of the disease. The fruit fly Drosophila melanogaster 32 is becoming a powerful model organism to study neurodegenerative diseases. We sought to use this system to explore olfactory dysfunction, if any, in PINK1 mutants, which is a model for PD. PINK1 mutants display many important diagnostic symptoms of the disease such as akinetic motor behavior. In the present study, we describe for the first time, to the best of our knowledge, neurophysiological and neuroanatomical results concerning the olfactory function in PINK1 mutant flies. Electroantennograms were recorded in response to synthetic and natural volatiles (essential oils) from groups of PINK1 mutant adults at three different time points in their life cycle: one from 3-5 day-old flies, from 15-20 and from 27-30 days. The results obtained were compared with the same age-groups of wild type flies. We found that mutant adults showed a decrease in the olfactory response to 1-hexanol, α-pinene and essential oil volatiles. This olfactory response in mutant adults decreased even more as the flies aged. Immunohistological analysis of the antennal lobes in these mutants revealed structural abnormalities, especially in the expression of Bruchpilot protein, a marker for synaptic active zones. The combination of electrophysiological and morphological results suggests that the altered synaptic organization may be due to a neurodegenerative process. Our results indicate that this model can be used as a tool for understanding PD pathogensis and pathophysiology. These results help to explore the potential of using olfaction as a means of monitoring PD progression and developing new treatments

Interactions between calliphoridae dipters and Helicodiceros muscivorus

This article reports on the experimental results of a research programme dealing with the reproductive strategies of Helicodiceros muscivorus (L. fil.) Engler(Araceae: Aroideae). In particular, the role played by the odorous mixture emanated by the vegetable species as olfactory information received by the insects, and the importance of that specific biological activity in governing the behavioural choices made by the pollinating insects is studied

Functional and morphological correlates in the drosophila LRRK2 loss-of-function model of Parkinson's disease: drug effects of Withania somnifera (Dunal) administration

The common fruit fly Drosophila melanogaster (Dm) is a simple animal species that contributed significantly to the development of neurobiology whose leucine-rich repeat kinase 2 mutants (LRRK2) loss-of-function in the WD40 domain represent a very interesting tool to look into physiopathology of Parkinson's disease (PD). Accordingly, LRRK2 Dm have also the potential to contribute to reveal innovative therapeutic approaches to its treatment. Withania somnifera Dunal, a plant that grows spontaneously also in Mediterranean regions, is known in folk medicine for its anti-inflammatory and protective properties against neurodegeneration. The aim of this study was to evaluate the neuroprotective effects of its standardized root methanolic extract (Wse) on the LRRK2 loss-of-function Dm model of PD. To this end mutant and wild type (WT) flies were administered Wse, through diet, at different concentrations as larvae and adults (L+/A+) or as adults (L-/A+) only. LRRK2 mutants have a significantly reduced lifespan and compromised motor function and mitochondrial morphology compared toWT flies 1% Wse-enriched diet, administered to Dm LRRK2 as L-/A+and improved a) locomotor activity b) muscle electrophysiological response to stimuli and also c) protected against mitochondria degeneration. In contrast, the administration of Wse to Dm LRRK2 as L+/A+, no matter at which concentration, worsened lifespan and determined the appearance of increased endosomal activity in the thoracic ganglia. These results, while confirming that the LRRK2 loss-of-function in the WD40 domain represents a valid model of PD, reveal that under appropriate concentrations Wse can be usefully employed to counteract some deficits associated with the disease. However, a careful assessment of the risks, likely related to the impaired endosomal activity, is require

An activator of voltage-gated K+ channels Kv1.1 as a therapeutic candidate for episodic ataxia type 1

Loss-of-function mutations in the KCNA1(Kv1.1) gene cause episodic ataxia type 1 (EA1), a neurological disease characterized by cerebellar dysfunction, ataxic attacks, persistent myokymia with painful cramps in skeletal muscles, and epilepsy. Precision medicine for EA1 treatment is currently unfeasible, as no drug that can enhance the activity of Kv1.1-containing channels and offset the functional defects caused by KCNA1 mutations has been clinically approved. Here, we uncovered that niflumic acid (NFA), a currently prescribed analgesic and anti-inflammatory drug with an excellent safety profile in the clinic, potentiates the activity of Kv1.1 channels. NFA increased Kv1.1 current amplitudes by enhancing the channel open probability, causing a hyperpolarizing shift in the voltage dependence of both channel opening and gating charge movement, slowing the OFF-gating current decay. NFA exerted similar actions on both homomeric Kv1.2 and heteromeric Kv1.1/Kv1.2 channels, which are formed in most brain structures. We show that through its potentiating action, NFA mitigated the EA1 mutation-induced functional defects in Kv1.1 and restored cerebellar synaptic transmission, Purkinje cell availability, and precision of firing. In addition, NFA ameliorated the motor performance of a knock-in mouse model of EA1 and restored the neuromuscular transmission and climbing ability in Shaker (Kv1.1) mutant Drosophila melanogaster flies (Sh5). By virtue of its multiple actions, NFA has strong potential as an efficacious single-molecule-based therapeutic agent for EA1 and serves as a valuable model for drug discovery

Sensilla on the antennal funiculus of the blow fly, Protophormia terraenovae (Diptera: Calliphoridae)

The morphology of the antennal funiculus and the external morphological characteristics and distribution of sensilla of blow fly, Protophormia terraenovae, have been studied using light and scanning electron microscopy. Cross section of the funiculus is roughly triangular in shape, with an anterior-medial, anterior-lateral, and posterior surface. The latter presents some large-size pits on restricted lateral and median areas of the proximal funiculus, and several smaller-size ones close to the pedicel–funiculus joint. The entire surface of the antennal sub-segment appears densely populated by microtrichia and is inhabited by seven types of sensilla: one trichoid, two basiconic, one auriculate, one coeloconic, and two basiconic-like pit sensilla. Trichoid, basiconic, auriculate and basiconic-like types display a multiporous wall, a feature characteristic of insect olfactory sensilla. It remains to be verified whether or not the coeloconic structure type has wall pores. The most abundant sensilla are the trichoid ones, which are followed by the basiconic, coeloconic and auriculate types in a decreasing density order. The basiconic-like pit sensilla are present only on the posterior funicular surface, unlike the remaining ones which populate the entire sub-segment. The blow fly’ funiculus displays a significant, even though moderate sexual dimorphism, the female sub-segment being bigger and presenting a higher number of trichoid and auriculate sensilla. The presence of multiple wall pores in most of sensilla types implies an olfactory modality for sensory neurons they accomodate, thus indicating that the blow fly’ funiculus is a plain olfactory organ

Drosophila Shaker mutant as model for studying the neurobiology of sleep and mood disorders: effects of lithium and memantine on protein expression, activity and sleep

Clinical studies show circadian rhythm dysfunctions involvement in mood disorders and research is focusing on sleep disorders as predictor of bipolar disorder (BP). Its pathophysiology involves ion dysregulation and acute manic patients showed increased glutamate levels. Lithium, although its exact mechanism is still poorly under- stood, remains the first choice for treating mania in BP. Preclinical studies however have demonstrated the efficacy of memantine a non-competitive NMDA receptor antagonist, as mood-stabilizing drug in patients lithium resistant. Hyperexcitability, motor hyperactivity and reduced sleep characterized the Drosophila melanogaster Shaker mutant ( Sh ). These flies, carrying a mutation in the K + Shaker channel alpha-subunit (the invertebrate counterpart of Kv1), present a delayed membrane repolarization causing severe phenotypical aberrations. We propose such mutant flies as a model to study the response to lithium and memantine exploring the effect on motor activity and sleep patterns. Sh mutants and their control lines have been fed a diet containing lithium or memantine at different concentrations for 3 weeks. Lifespan, twenty-four hour motor activity (DAMS, Trikinetics) and sleep have been measured at the end of treatment. Brains from all groups have been processed for Western Blot analysis. Memantine affects Sh mutants sleep pattern improving quality and rhythm, reduces activity and increase life span. Western blot analysis reveals increased NMDAR1 protein expression in Sh mutants, restored to normal levels after memantine. Preliminary results in lithium fed flies showed some effects on motor activity and sleep. Our model is a promising tool and a valid alternative to rodents models of human diseases